Galapagos N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 01 may 2018 - 22:01
  • Statutory name Galapagos N.V.
  • Title Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients

Related downloads

201805010000000021_Star IGUANA Ph2 MOR106.pdf
201805010000000021_Start IGUANA Ph2.pdf

Date last update: 16 February 2019

Share information

Share on: Share this